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Abstract 
Cytochrome h-559 reconstituted with phospholipids and FAD represents the simplest model of the respiratory burst NADPH oxidase 
and reproduces the main catalytic features of this system (Koshkin. V. and Pick, E. (1993) FEBS Lett. 327, 57-62; (1994) FEBS Lett. 
338, 285-289). In the present report it is shown that activation by oxygen, characteristic of the NADPH oxidase complex, is an intrinsic 
property of flavocytochrome b-559, in principle independent of its complexation with the other components of NADPH oxidase. 
Facilitation of electron transfer from NADPH to FAD is found to be the reason for this phenomenon. Kinetic studies of anaerobic 
operation of flavocytochrome b-559 revealed the functional heterogeneity of two hemes, manifested as a dramatic difference in their 
reducibility under these conditions. 
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1. Introduction 
Superoxide production in phagocytic cells, known as 
respiratory burst, is catalyzed by an NADPH oxidase 
complex, consisting of a membrane-bound cytochrome 
6-559 and three cytosolic proteins (p47-phox, p67-phox 
and the small G-protein rucl p21 or ruc2 ~21) [l-5]. 
Recent studies of this complex in the cell-free system [6,7] 
led to the concept that cytochrome b-559 is the only 
catalytic component of NADPH oxidase, containing, in 
addition to two hemes, FAD- and NADPH-binding do- 
mains, and catalyzing electron transfer in the sequence 
NADPH -+ FAD + heme -+ 0, [8-lo]. The function of 
cytosolic proteins, according to this concept, is to bring 
this electron transport chain from the dormant to the active 
state. On the other hand, it was found that the cytochrome 
b-559 heme can also be reduced by foreign flavoproteins 
[ 1 1 - 131, including one from neutrophil membranes [ 14,151. 
Recently we demonstrated the cytochrome b-559 ability 
to function as an independent generator of 0; in vitro, 
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provided that it is incorporated into phospholipid vesicles 
of a certain composition [ 161. This offers a direct func- 
tional proof for the catalytic competence of cytochrome 
b-559 and a useful model to study the enzymology of the 
respiratory burst [ 17-191. It is known that oxygen is a 
requirement for efficient electron flow within the NADPH 
oxidase complex, and the rate of anaerobic heme reduction 
accounts for less than 10% of the aerobic steady-state 
turnover [20,2 1 I. Possible explanations include a confor- 
mational change in NADPH oxidase caused by oxygen 
binding [20], or such kinetic organization of this system 
that the presence of oxidant is necessary for its rapid 
functioning [20,22]. In the present work I undertook an 
investigation of the influence of oxygen on the operation 
of flavocytochrome b-559 reconstituted with phospho- 
lipids. It is shown that activation by oxygen is character- 
istic of flavocytochrome b-559 itself, and its behaviour in 
aerobic and anaerobic conditions is explored. 
2. Materials and methods 
Cytochrome b-559 in catalytically active state was ob- 
tained essentially as described earlier [ 19,231. Cytochrome 
b-559 was solubilized from high-speed-sedimented frac- 
tion of prewashed guinea-pig peritoneal macrophage mem- 
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branes [19] with 40 mM octyl glucoside in buffer A (0.05 
M sodium phosphate (pH 7.4), 1 mM MgCl,, 1 mM 
EGTA, 20% glycerol) in the presence of 1 mM PMSF and 
1 pg/ml of leupeptin. Further purification included affin- 
ity chromatography on heparin agarose and resulted in 
cytochrome b-559 preparations with a specific content of 
4-6 nmol heme/mg protein. The concentration of cy- 
tochrome b-559 heme was calculated from differential 
reduced minus oxidized spectra using the extinction coef- 
ficient (427-411 nm) = 200 mM_’ cm-’ [24]. Protein 
concentration was measured by the method of Bradford 
[25] with bovine serum albumin as the standard. 
For activation, cytochrome b-559 was incorporated into 
vesicles consisting of azolectin-phosphatidic acid in the 
following way: cytochrome-containing fractions, after 
affinity chromatography, were concentrated by ultrafiltra- 
tion to a concentration of 4-6 PM, supplemented with 
phospholipids (L-cY-phosphatidylcholine, type IV, and 
phosphatidic acid from egg yolk lecithin, both from Sigma, 
130 pug/ml of each) and frozen at - 75°C. After thawing, 
cytochrome b-559-containing vesicles possessing superox- 
ide producing activity were formed by dialysis against 
detergent-free buffer A. This material was kept until use at 
- 75°C. 
FAD binding properties of this system were studied by 
the fluorometric titration with FAD. As we have shown 
earlier, binding to cytochrome b-559 results in quenching 
of FAD fluorescence [17], specificity of this quenching is 
confirmed by the fact that cytochrome b-559 in inactive 
state, i.e., devoid of activating phospholipids, does not 
quench fluorescence of added FAD. The normalized fluo- 
rescence quenching (qnorm = q/qma,), that can serve as a 
measure of protein liganding [26], was calculated by com- 
parison with the control cytochrome-free vesicles. The 
plots of this value against total FAD added were fitted to 
the equation of equilibrium binding K = (b - l~fX,f- 
l$)/bf, that was rearranged to the form: 
Lf/b=(K+b+f)/2b- [(K+b+f)/2b]*-f/b 
(1) 
in order to express fractional saturation of cytochrome 
b-559 with FAD as a function of the total FAD concentra- 
tion (K denotes the dissociation constant, b and f total 
concentrations of cytochrome b-559 and FAD, and bf 
concentration of the cytochrome b-559-FAD complex). 
Electron transport in this system in the presence of 
NADPH, superoxide dismutase (SOD) and catalase was 
followed by spectral scanning in the range 360-600 nm 
with 10 s intervals using a diode-array spectrophotometer 
(HP-8452A; Hewlett-Packard). A time-course of NADPH 
oxidation and oxidoreduction of heme was derived from 
these spectra at the wavelengths 366 and 558-540 nm, 
respectively (contribution of FAD to NADPH absorbance 
was no more than 0.2%). Separate samples of identical 
composition were used to monitor oxidoreduction of FAD 
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Fig. I. Reaction time course for NADPH (upper panel, solid line, left 
Y-axis), 0, (upper panel, dotted line, right Y-axis), heme b-559 (middle 
panel) and FAD (lower panel) during aerobic and anaerobic operation of 
flavocytochrome h-559. Phospholipid-reconstituted cytochrome b-559 in 
buffer A (1.19 PM of heme, 130 hg/ml of phosphatidylcholine, 130 
pg/ml of phosphatidic acid) was supplemented with 0.58 KM of FAD, 
30 WM of LiDS, 75 U/ml of SOD, 257 U/ml of catalase and 150 mM 
of glucose. The reaction was started by the addition of 0.66 mM of 
NADPH (arrow marked 1). aerobiosis was maintained by the stirring of 
the cuvette content between spectral scans, anaerobiosis was achieved by 
the addition of 12 U/ml of glucose oxidase and covering of the cuvette 
content by the paraffin oil (arrow marked 2). This was followed by the 
oxygen pulse (addition of 20 ~1 of buffer A bubbled with oxygen for 10 
min, arrow marked 3); finally the system was completely reduced by 
dithionite (arrow marked 4). 
group by fluorometry (at 490 + 550 nm to avoid interfer- 
ence from excess of NADPH) and oxygen consumption by 
polarography. Steady-state aerobic functioning of cy- 
tochrome b-559 was maintained in the samples open to 
atmospheric oxygen by periodic stirring (every 10 s), to 
achieve anaerobic state the samples were supplemented 
with the oxygen-scavenging system glucose-glucose oxi- 
dase and covered by the paraffin oil [27] (kinetics of the 
oxygen depletion due to combined process of glucose and 
NADPH oxidation is shown in Fig. 1). Kinetic curves of 
heme and FAD reduction were fitted to the single or 
double exponential kinetics: 
Absorbance( fluorescence) = a, [ 1 - exp( - k, t)] 
+a,[1 -exp(-k2f)l (2) 
from which first-order rate constants (k) and amplitudes 
(a> were obtained. 
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Experiments were carried out in the presence of 30 PM 
of lithium dodecyl sulfate (LIDS), which is known as a 
moderate activator of this system [ 161. 0; production was 
quantitated by the initial rate of SOD-inhibitable cy- 
tochrome c reduction, essentially as described before [16]. 
All fluorometric measurements were performed with a 
FP-770 spectrofluorometer (Jasco); for routine absorbance 
measurements a Uvikon 860 spectrophotometer (Kontron) 
was used and oxygen consumption was measured with the 
micro probe of a YSI 53 oxygen monitor (Yellow Springs 
Instruments). Fitting and plotting procedures were per- 
formed using SigmaPlot scientific graphing software 
(Jandel Scientific Co.). 
3. Results and discussion 
Fig. 1 demonstrates the time course of NADPH oxida- 
tion, kinetics of oxygen depletion and redox state of FAD 
and heme centers during aerobic and anaerobic operation 
of cytochrome b-559. The first aerobic part of this diagram 
shows the process of steady-state NADPH oxidation with 
the low stationary level of FAD and heme reduction (9 and 
30/o, respectively), so that electron flows on the separate 
steps are viV,lX’ii + FAD = ‘FAD + heme = vheme + oxygen = 
k[heme’+] [20], where k is the pseudo-first-order rate 
constant for heme oxidation. The value of 186 s-’ can be 
calculated for the last parameter (from the rate of NADPH 
oxidation of 5.59 pequiv/s and the steady-state concentra- 
tion of reduced heme of 0.03 PM), which is close to the 
value of 147 s- ’ reported earlier for the whole NADPH 
oxidase complex [20,28]. K, for 0, was estimated by a 
separate run of oxygen consumption (data not shown) and 
found to be about 10 /IM, which is also close to the 
corresponding parameter of the native system [29,30]. 
When oxygen was exhausted, the steady-state electron 
flow through the system ceased and the reduction of flavin 
and heme above the stationary level started with initial 
rates of 0.005 and 0.009 pequiv/s, respectively. When 
this reduction was nearly completed a small amount of 
oxygen was introduced into the system, and after its 
depletion dithionite was added. 
The discrepancy between velocities of aerobic function- 
ing (5.59 pequiv/s) and anaerobic reduction (0.014 
pequiv/s) of flavocytochrome prosthetic groups suggests 
that in anaerobic state electron transfer within this system 
is strongly inhibited. This inhibition was reversible judging 
by the effect of the small oxygen pulse on NADPH 
oxidation. As both FAD and heme undergo only slow 
reduction under anaerobic conditions, the site in the elec- 
tron transport chain affected by anaerobiosis is situated 
before these centers, namely, at the step of binding or 
oxidation of NADPH. The lowering of NADPH concentra- 
tion to the level of K, for the aerobic state had a minor 
effect on the rate of anaerobic heme reduction; hence, in 
the anaerobic state the system can be saturated with 
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Fig. 2. Cytochrome b-559 titration with FAD. Phospholipid-reconstituted 
cytochrome b-559 in buffer A (I .08 PM of heme. 130 ~_~g/ml of 
phosphatidylcholine, 130 Fg/ml of phosphatidic acid) was supplemented 
with 30 PM of LiDS and titrated with FAD with the parallel measure- 
ment of the fluorescence (lower panel, filled circles-titration of cy- 
tochrome b-559. open circles-titration of the control cytochrome-free 
phospholipid vesicles) and superoxide-producing activity (upper panel). 
The normalized fluorescence quenching derived from fluorescence titra- 
tion was fitted to the equation of equilibrium binding (Materials and 
methods, Eq. (I)) (middle panel, dots - experimental data; line - 
theoretical curve with b = 0.42 PM and K = 0.024 FM). 
NADPH more easily and anaerobiosis hinders NADPH 
oxidation rather than its binding. 
It is noteworthy that, as apparent in Fig. 1, when the 
reduction of FAD was practically complete, the heme 
reduction did not exceed half-maximal level. A similar 
situation is known for the complete NADPH oxidase com- 
plex and in order to explain it, the existence of inactive 
fraction of cytochrome b-559 was supposed [28,31]. In the 
present system, the state of cytochrome b-559 can be 
characterized precisely by its titration with FAD, which 
provides an estimation of its FAD-binding capacity and of 
the catalytic efficiency of its reflavinated form. Typical 
data illustrating this approach are presented in Fig. 2. 
Fluorometric titration of cytochrome b-559 with FAD was 
performed (lower panel) and a plot of the normalized 
fluorescence quenching against added FAD (middle panel) 
was fitted to dependence of fractional protein liganding on 
total ligand added (see Materials and methods, Eq. (I)). 
This gives a Kdih of 0.024 PM and the concentration of 
binding sites of 0.42 PM, which corresponds to approxi- 
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Fig. 3. Kinetics of the anaerobic heme and FAD reduction in flavocy- 
tochrome h-559. Phospholipid-reconstituted cytochrome b-559 (I .20 PM 
of heme, 130 Fg/ml of phosphatidylcholine, 130 Fg/ml of phosphatidic 
acid) in the same medium as in Fig. I was brought into anaerobic state 
with the aid of glucose oxidase, the reaction was started by the addition 
of deoxygenated NADPH solution to a final concentration of 0.70 mM at 
zero time. The FAD reduction (lower panel, solid line) was fitted to the 
single exponential kinetics (dashed line), and the heme reduction (upper 
panel, solid line) to the single and double exponential kinetics (dotted and 
dashed lines, respectively). 
mately 80% of cytochrome b-559 present ([cytochrome 
b-559 heterodimer] = [heme b-5591/2). A gradual growth 
of superoxide producing activity of cytochrome b-559 in 
the course of titration was measured, normalized and plot- 
ted as a function of the FAD/cytochrome b-559 ratio 
(upper panel). The initial linear part of this curve, repre- 
senting the region of stoichiometric FAD binding, has a 
slope of 0.8 and indicates that 80% of cytochrome b-559 is 
accessible to activation. Thus, both FAD-binding capacity 
and catalytic activity show 80% degree of cytochrome 
b-559 activation; at the same time only 38% of heme in 
this preparation was readily reducible under anaerobic 
conditions (Fig. 1). Therefore it seems reasonable to sup- 
pose that the cause for incomplete heme reduction is 
heterogeneity of two hemes in the cytochrome b-559 
molecule, only one of them being easily accessible to 
reduction in an anaerobic state. 
More detailed kinetic investigation of anaerobic reduc- 
tion of redox centers in flavocytochrome b-559 is shown 
in Fig. 3, where kinetic traces of FAD fluorescence and 
heme absorbance are fitted to the single or double expo- 
nential kinetics (see Materials and methods, Eq. (2)). The 
reduction of FAD looks like a single exponential reaction 
with a first-order rate constant of 0.017 s- ’ , although this 
is only an apparent value reflecting a complex process of 
FAD reduction by NADPH and its oxidation by hemes. 
The heme reduction is clearly better approximated by the 
double than by the single exponential kinetics with equal 
amplitudes of both phases and rate constants of 0.0476 and 
0.0009 s-‘. Inequivalence of hemes in cytochrome b-559 
was suggested first by Iizuka et al. [32] from the low-tem- 
perature absorbance spectra and by Hurst et al. [33] from 
the data on cytochrome b-559 photoreduction. On other 
hand, cytochrome b-559 hemes behave as a thermodynam- 
ically and kinetically homogeneous pool in reduction by 
dithionite [28,33-351 and oxidation by oxygen and ferri- 
cyanide [ 13,20,28,33]. One can suppose that two hemes are 
differently located in the protein molecule, so that they are 
equally accessible to external reductants and oxidants but 
differ in accessibility to reduction by the bound FAD, at 
least under anaerobic conditions. 
In conclusion, the data presented show that activation 
by oxygen (as well as the kinetics of interaction with it) is 
an intrinsic property of flavocytochrome b-559, in princi- 
ple independent of its complexation with other components 
of NADPH oxidase. In this relation it resembles such 
redox enzymes, as cytochrome c oxidase [36], ascorbate 
oxidase and lactase [37], although underlying mechanisms 
in each case could be different. This activation is due to 
acceleration of FAD reduction, and suggests that interac- 
tion of some kind with oxygen precedes an efficient 
electron transfer within flavocytochrome b-559 and results 
in its conversion from the slow to the fast operating state. 
In the slow state of cytochrome b-559, the two hemes 
differ greatly in their ability to accept electrons from FAD; 
the question whether there is any difference between hemes 
in the fast aerobic state requires further investigation. 
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